Patent Tracker
Applications for patents related to psychedelics have boomed in recent years. Nonprofits, pharmaceutical companies, startups, and academic institutions are all jockeying to patent specific psychedelic compounds and formulations. To help keep tabs on the status of patent applications as they wind their way through the U.S. Patent and Trademark’s review process, BCSP has collaborated on a patent tracker with Psychedelic Alpha, an independent media outlet, community and consultancy firm in the psychedelic field, and Calyx Law, a patent law boutique focusing on cannabis and psychedelics related IP. Read more about the history and process of psychedelic patents here.
1282 Patents
Psilocybin & Psilocin
Title
Methods of treating disorders with a psilocybin analog
Subject Matter
Methods of treating various diseases, disorders, and conditions, such as depressive disorders (e.g., Major Depressive Disorder (MDD)), substance use disorders, anxiety disorders, eating disorders, pain, and headache disorders via administration of deuterated psilocin and pharmaceutically acceptable salts, polymorphs, or solvates thereof.
Psilocybin & Psilocin
Title
Enhancement of the efficacy of serotonergic psychedelic drugs in the treatment or prevention of certain neuropsychiatric disorders through inhibition of type-9 phosphodiesterases
Subject Matter
Compositions and methods for treating diseases or disorders using a therapeutically effective amount of a serotonergic psychedelic drug and a therapeutically effective amount of a phosphodiesterase type 9 inhibitor.
Owner
Freedom Biosciences, Inc.
Patent Number
US20250360137Priority Date
11.15.2022
Status
Published
Psilocybin & Psilocin
Title
Method And Use Of Psilocybin In The Prevention And Treatment Of Stroke
Subject Matter
Methods for the prevention and treatment of stroke in a mammal including administering a therapeutically effective amount of psilocybin or a pharmaceutically acceptable salt or solvate thereof.
Psilocybin & Psilocin
Title
Extraction system for extraction of volatile and non-volatile products from biomass, methods of using the same
Subject Matter
Systems for extraction of volatile and non-volatile products from a fungal or plant biomass.
Ibogaine
Title
Salt forms of ibogaine
Subject Matter
Salt forms of ibogaine.
Owner
Atai Therapeutics, Inc.
Patent Number
WO2025230894Priority Date
04.29.2024
Status
PCT Published
Psilocybin & Psilocin
Title
Solid dispersions of psilocybin
Subject Matter
Stable pharmaceutical compositions of amorphous psilocybin and deuterated psilocybin, and to the use of such pharmaceutical compositions in the treatment of diseases associated with a serotonin 5-HT.sub.2 receptor.
Psilocybin & Psilocin
Title
Stabilization Of Tryptamines By Denaturing Enzymes, Optimizing Ionization States, And Controlling Confounding Variables
Subject Matter
Improved methods to both stabilize tryptamines and prepare partially-purified tryptamine extracts for use in commercial products.
LSD
Title
Pharmaceutical composition for preventing or treating mental disorder
Subject Matter
Pharmaceutical composition for preventing or treating a mental disorder.
Psilocybin & Psilocin
Title
Extracellular vesicles from microalgae, their biodistribution upon intranasal administration, and uses thereof
Subject Matter
Compositions containing microalgae extracellular vesicles (MEVs) formulated for intranasal delivery.
Psilocybin & Psilocin
Title
Compositions and uses of psilocybin and psilocin
Subject Matter
A method of treating or ameliorating a disease or disorder comprising administering to a subject a crystalline form of a composition comprising crystalline forms A, B, and C of psilocin and psilocybin.
Page 1 of 129